What the evidence says. Early or small human trials; promising but not yet conclusive.
Nutrition per serving ~7 small fruits (100 g)
Water88 g89%
Sugars1.7 g2%
Fibre2.8 g3%
Other carbs6 g6%
Protein0.7 g1%
Fat0.2 g0%
What's in one serving, by weight — average composition (USDA).One serving as % of the adult daily requirement (FDA Daily Values). The bold outer ring = 100% of a day's needs.
Calamansi (Citrus x microcarpa) is a fruit used for good vitamin c source supporting antioxidant defense and normal immune function. NutriDex grades the human evidence as Preliminary. Calamansi (calamondin) is a small Southeast Asian citrus prized as an acidulant; its juice and especially its peel concentrate vitamin C, the polymethoxyflavones nobiletin and tangeretin, the flavanone hesperidin, and the dihydrochalcone DGPP. Chemical-marker analysis quantified DGPP at roughly 25 mg/100 mL and nobiletin at about 2.4 mg/100 mL in calamondin juice. Direct human clinical trials on calamansi itself are essentially absent, so claims rest on (1) preclinical calamondin studies and (2) extrapolation from well-studied isolated citrus constituents. In high-fat-diet mice, 1–5% dietary calamondin puree slowed non-alcoholic fatty-liver progression and improved glucose tolerance. For its individual flavonoids, randomized human trials of hesperidin show modest reductions in systolic blood pressure, LDL and triglycerides, citrus polymethoxyflavones lowered cholesterol substantially in hypercholesterolemic hamsters, and vitamin C reviews show small reductions in cold duration and severity—but these used purified compounds or other citrus, not calamansi. The fruit is genuinely nutrient-dense and a healthy low-calorie flavoring, yet the species-specific human evidence is preliminary. Treat cardiometabolic and antidiabetic claims as plausible-but-unproven in people.
Purported Benefits
✓Good vitamin C source supporting antioxidant defense and normal immune function
✓Contains polymethoxyflavones (nobiletin, tangeretin) and the flavanone hesperidin, citrus compounds with lipid-metabolism activity documented in animal and human-isolated-compound research
✓Anti-hyperglycemic and glucose-tolerance effects in preclinical (animal/in vitro) models
✓Slowed non-alcoholic fatty-liver progression in high-fat-diet mice fed calamondin puree
✓Antioxidant peel phenolics (DGPP, hesperidin) with in vitro free-radical scavenging activity
✓Low-calorie acidulant useful as an alternative to added salt or sugar in cooking
Dosing & Compounds
Typical Dose
2–4 fruits' juice (about 15–30 mL) as a souring agent, or ~100 g whole fruit (roughly 7 small fruits) per use; no established therapeutic dose in humans.
Highly acidic—erosive to tooth enamel and may aggravate GERD, reflux or mouth ulcers; dilute the juice. True citrus allergy or oral-allergy syndrome is possible. Unlike grapefruit, calamansi/calamondin is not an established CYP3A4 furanocoumarin inhibitor, but data are limited—use caution and consult a clinician if on narrow-therapeutic-index drugs. Vitamin C from concentrated juice or supplements above ~2 g/day can cause GI upset and, in predisposed people, may raise kidney-stone (oxalate) risk. Peel/seed extracts used in studies are far more concentrated than culinary intake and are not standardized supplements. Educational only — always check with your doctor or pharmacist before combining Calamansi with any medicine.
Calamansi is most often taken for Good vitamin C source supporting antioxidant defense and normal immune function, Contains polymethoxyflavones (nobiletin, tangeretin) and the flavanone hesperidin, citrus compounds with lipid-metabolism activity documented in animal and human-isolated-compound research, Anti-hyperglycemic and glucose-tolerance effects in preclinical (animal/in vitro) models, Slowed non-alcoholic fatty-liver progression in high-fat-diet mice fed calamondin puree. Tiny Filipino lime with outsized citrus bioactives
Does Calamansi work — what does the evidence say?
Preliminary evidence. Early or small human trials; promising but not yet conclusive. Calamansi (calamondin) is a small Southeast Asian citrus prized as an acidulant; its juice and especially its peel concentrate vitamin C, the polymethoxyflavones nobiletin and tangeretin, the flavanone hesperidin, and the dihydrochalcone DGPP. Chemical-marker analysis quantified DGPP at roughly 25 mg/100 mL and nobiletin at about 2.4 mg/100 mL in calamondin juice. Direct human clinical trials on calamansi itself are essentially absent, so claims rest on (1) preclinical calamondin studies and (2) extrapolation from well-studied isolated citrus constituents. In high-fat-diet mice, 1–5% dietary calamondin puree slowed non-alcoholic fatty-liver progression and improved glucose tolerance. For its individual flavonoids, randomized human trials of hesperidin show modest reductions in systolic blood pressure, LDL and triglycerides, citrus polymethoxyflavones lowered cholesterol substantially in hypercholesterolemic hamsters, and vitamin C reviews show small reductions in cold duration and severity—but these used purified compounds or other citrus, not calamansi. The fruit is genuinely nutrient-dense and a healthy low-calorie flavoring, yet the species-specific human evidence is preliminary. Treat cardiometabolic and antidiabetic claims as plausible-but-unproven in people.
What is the typical dose of Calamansi?
2–4 fruits' juice (about 15–30 mL) as a souring agent, or ~100 g whole fruit (roughly 7 small fruits) per use; no established therapeutic dose in humans.
Is Calamansi safe? Any cautions or side effects?
Highly acidic—erosive to tooth enamel and may aggravate GERD, reflux or mouth ulcers; dilute the juice. True citrus allergy or oral-allergy syndrome is possible. Unlike grapefruit, calamansi/calamondin is not an established CYP3A4 furanocoumarin inhibitor, but data are limited—use caution and consult a clinician if on narrow-therapeutic-index drugs. Vitamin C from concentrated juice or supplements above ~2 g/day can cause GI upset and, in predisposed people, may raise kidney-stone (oxalate) risk. Peel/seed extracts used in studies are far more concentrated than culinary intake and are not standardized supplements.
How many studies support Calamansi?
NutriDex cites 9 sources for Calamansi, graded "Preliminary".
Cite this page
APA
Peh, D. (2026). Calamansi (Citrus x microcarpa): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 16 Sept 2026, from https://nutridex.info/s/calamansi
BibTeX
@misc{nutridex_calamansi,
author = {Peh, Daryl},
title = {Calamansi (Citrus x microcarpa): Benefits, Dosage, Side Effects \& Evidence},
year = {2026},
howpublished = {NutriDex --- The Supplement Research Compendium},
url = {https://nutridex.info/s/calamansi},
note = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-09-16}
}
For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.